Medicaid Gets Higher Rebates For Brand Drugs Compared To Medicare Part D, OIG Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Findings could carry extra significance as congressional "super committee" looks for ways to cut at least $1.2 trillion in federal spending.